Radisson Plaza-Warwick Hotel Philadelphia, Philadelphia, PA
July 21-23, 2004
As renewed hope for better success have emerged from the use of molecular biology to identify unique attributes of tumor cells that can be targeted as drug candidates, numerous agents are now in various stages of development. The finest group of oncology experts has been assembled at this meeting to address the most promising therapeutics including molecular targeted agents, antibodies, vascular targeting and more. Join high-level industrial cancer researchers and business development personnel worldwide at this widely attended conference.
|
|